CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...